BILL vs BMY · rev $1.65B vs P/E 17, rev $24.46B
Bill Com Holdings Inc (BILL) versus Bristol-Myers Squibb Company (BMY) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
BILL currently screens at market cap $4.78B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Not investment advice. Open the BILL and BMY stock pages for the full models.
Not investment advice.